SCHEMBL19769239

SCHEMBL19769239

CN1CCc2nc3sc(C(N)=O)c(N)c3cc2C1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.73
CYP1A2 P05177 1/20 0.73
CYP2C19 P33261 1/20 0.73
MAPT P10636 12/20 0.72
KDM4E B2RXH2 5/20 0.72
KMT2A Q03164 4/20 0.72
MEN1 O00255 3/20 0.72
POLB P06746 3/20 0.70
LMNA P02545 1/20 0.70
HSP90AA1 P07900 1/20 0.70
GAA P10253 1/20 0.70
HPGD P15428 1/20 0.70
PTK2B Q14289 1/20 0.70
SHMT2 P34897 1/20 0.70
NPSR1 Q6W5P4 2/20 0.67
ADORA2A P29274 1/20 0.67
USP2 O75604 1/20 0.67
THRB P10828 1/20 0.67
ALOX15 P16050 1/20 0.67
CASP1 P29466 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14954741 0.91 ALDH1A1 (0.73) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL15788373 0.87 ALDH1A1 (0.79) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL428803 0.85 ALDH1A1 (0.76) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL30093344 0.85 MAPT (0.66) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL13186294 0.85 MAPT (0.77) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL430708 0.85 MAPT (0.67) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL429191 0.85 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL428713 0.84 MAPT (1.00) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL17792672 0.83 SHMT2 (1.00) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL428804 0.83 MAPT (0.75) ALDH1A1CYP1A2CYP2C19MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180015077-A1 COMPOUNDS AND METHODS FOR TREATING HIV INFECTION NAKAMURA, ROBERT 2018-01-18 US disclosed
US-20180015077-A1 COMPOUNDS AND METHODS FOR TREATING HIV INFECTION NAKAMURA, ROBERT 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180015077-A1 COMPOUNDS AND METHODS FOR TREATING HIV INFECTION CD4, CCR5, MMP8 ALDH1A1 482/4885CYP1A2 1258/4885CYP2C19 1838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.